A phase I study of E7080 in patients (pts) with advanced malignancies

被引：0
|
作者：
Glen, H.
Boss, D. R.
Morrison, R.
Roelvink, M.
Wanders, J.
Mazur, A.
Gupta, A.
Das, A.
Evans, T. R.
Schellens, J. H.
机构：
[1] Beatson Inst Canc Res, Glasgow G61 1BD, Lanark, Scotland
[2] Nederlands Kanker Inst, Amsterdam, Neth Antilles
[3] Beatson W Scotland Canc Ctr, Glasgow, Lanark, Scotland
[4] Eisai Med Res, London, England
[5] Univ Glasgow, Glasgow, Lanark, Scotland
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3526
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Treatment of advanced solid tumors with golvatinib (E7050) in combination with lenvatinib (E7080)
    Kwak, E. L.
    Juric, D.
    Cleary, J. M.
    Cote, G.
    Hilton, J. F.
    Flaherty, K. T.
    Wood, K.
    Rance, C.
    Barrett, S.
    Shapiro, G. I.
    [J]. EUROPEAN JOURNAL OF CANCER, 2014, 50 : 158 - 158
  • [22] A Phase II Trial of the Multitargeted Tyrosine Kinase Inhibitor Lenvatinib (E7080) in Advanced Medullary Thyroid Cancer
    Schlumberger, Martin
    Jarzab, Barbara
    Cabanillas, Maria E.
    Robinson, Bruce
    Pacini, Furio
    Ball, Douglas W.
    McCaffrey, Judith
    Newbold, Kate
    Allison, Roger
    Martins, Renato G.
    Licitra, Lisa F.
    Shah, Manisha H.
    Bodenner, Donald
    Elisei, Rossella
    Burmeister, Lynn
    Funahashi, Yasuhiro
    Ren, Min
    O'Brien, James P.
    Sherman, Steven I.
    [J]. CLINICAL CANCER RESEARCH, 2016, 22 (01) : 44 - 53
  • [23] A Phase I study of indoximod in patients with advanced malignancies
    Soliman, Hatem H.
    Minton, Susan E.
    Han, Hyo Sook
    Ismail-Khan, Roohi
    Neuger, Anthony
    Khambati, Fatema
    Noyes, David
    Lush, Richard
    Chiappori, Alberto A.
    Roberts, John D.
    Link, Charles
    Vahanian, Nicholas N.
    Mautino, Mario
    Streicher, Howard
    Sullivan, Daniel M.
    Antonia, Scott J.
    [J]. ONCOTARGET, 2016, 7 (16) : 22928 - 22938
  • [24] A phase II trial of the multitargeted kinase inhibitor lenvatinib (E7080) in advanced medullary thyroid cancer (MTC).
    Schlumberger, Martin
    Jarzab, Barbara
    Cabanillas, Maria E.
    Robinson, Bruce
    Pacini, Furio
    Ball, Douglas Wilmot
    McCaffrey, Judith C.
    Newbold, Kate
    Allison, Roger
    Martins, Renato
    Licitra, Lisa F.
    Shah, Manisha H.
    Bodenner, Donald
    Elisei, Rossella
    Burmeister, Lynn A.
    Funahashi, Yasuhiro
    Sellecchia, Rita
    Andresen, Corina
    O'Brien, James P.
    Sherman, Steven I.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [25] Phase I trial of SNS-595 in patients (pts) with advanced malignancies.
    Advani, R
    Gordon, M
    Hurwitz, H
    Mendelson, D
    Wakelee, H
    Ebbinghaus, S
    Hoch, U
    Silverman, J
    Havrilla, N
    Adelman, D
    [J]. CLINICAL CANCER RESEARCH, 2005, 11 (24) : 9056S - 9056S
  • [26] Phase I trial of SU014813 in patients (pts) with advanced solid malignancies
    Fiedler, W. M.
    Giaccone, G.
    Lasch, P.
    Van der Horst, I.
    Brega, N. M.
    Raber, S.
    Shalinsky, D.
    Ljubmir, V.
    Bokemeyer, C.
    Boven, E.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [27] Phase I and pharmacokinetic (PK) study of dasatinib (D) and cetuximab (C) in patients (pts) with advanced solid malignancies
    Feinstein, T. M.
    Agrawal, S.
    Stoller, R. G.
    Egorin, M. J.
    Argiris, A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [28] A phase I study to evaluate safety, tolerability, pharmacokinetics and activity of oraxol in patients (pts) with advanced malignancies.
    Ma, Wen Wee
    Azad, Nilofer Saba
    Lam, Elaine Tat
    Diamond, Jennifer Robinson
    Dy, Grace K.
    Opyrchal, Mateusz
    Gallagher, Denise
    Brennen, Caden
    Cutler, David
    Kramer, Douglas
    Chan, Wing Kai
    Kwan, Rudolf
    Fetterly, Gerald J.
    Adjei, Alex A.
    Jimeno, Antonio
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [29] Phase I/II study of MAK683 in patients (pts) with advanced malignancies including epithelioid sarcoma
    Bahleda, R.
    Wainberg, Z. A.
    Spreafico, A.
    Ma, B.
    Subbiah, V.
    Ribrag, V.
    Duca, M.
    Fan, Y. Y.
    Cheng, Y.
    Lai, C.
    De Braud, F.
    [J]. ANNALS OF ONCOLOGY, 2021, 32 : S1113 - S1114
  • [30] A phase I combination study of irofulven (IROF) and gemcitabine (GEM) in patients (pts) with advanced solid malignancies.
    O'Bryant, CL
    Gore, L
    Long, M
    Gustafson, D
    Eppers, S
    Basche, M
    Rothenberg, M
    Weems, G
    Shah, A
    Herdrich, L
    Eckhardt, SG
    Berlin, J
    [J]. CLINICAL CANCER RESEARCH, 2005, 11 (24) : 9119S - 9120S
12345